A decade's studies on metastasis of hepatocellular carcinoma

Journal of Cancer Research and Clinical Oncology

Volumn 130, Issue 4, 2004, Pages 187-196

  Tang, Zhao You ^a   Ye, Sheng Long ^a   Liu, Yin Kun ^a   Qin, Lun Xiu ^a   Sun, Hui Chuan ^a   Ye, Qin Hai ^a   Wang, Lu ^a   Zhou, Jian ^a   Qiu, Shuang Jian ^a   Li, Yan ^a   Ji, Xue Ning ^a   Liu, Hu ^a   Xia, Jing Ling ^a   Wu, Zhi Quan ^a   Fan, Jia ^a   Ma, Zeng Chen ^a   Zhou, Xin Da ^a   Lin, Zhi Ying ^a   Liu, Kang Da ^a  

^a ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

cDNA microarray; Experimental intervention; Hepatocellular carcinoma; Metastasis; Prediction of metastasis; Proteomics

Indexed keywords

5 AMINO 1 [3,5 DICHLORO 4 (4 CHLOROBENZOYL)BENZYL] 1H 1,2,3 TRIAZOLE 4 CARBOXAMIDE; ALPHA INTERFERON; ANGIOGENESIS INHIBITOR; ANTIMETASTATIC AGENT; ANTISENSE OLIGODEOXYNUCLEOTIDE; BATIMASTAT; CAPECITABINE; CYTOKERATIN 19; DOXIFLURIDINE; ENDOSTATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOROURACIL; HEPARIN; NUCLEOSIDE DIPHOSPHATE KINASE A; OSTEOPONTIN; PEPTIDE DERIVATIVE; PROTEIN P16; PROTEIN P21; PROTEIN P53; SURAMIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR ALPHA; VASCULOTROPIN;

ANIMAL CELL; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; CANCER GENETICS; CANCER GROWTH; CANCER INVASION; CELL CLONING; CHROMOSOME 8; CHROMOSOME DELETION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DENSITY; DNA MICROARRAY; DRUG EFFECT; FLUORESCENCE IN SITU HYBRIDIZATION; GEL ELECTROPHORESIS; GENE EXPRESSION PROFILING; GENE FUNCTION; GENOTYPE; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LUNG METASTASIS; METASTASIS; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; REVIEW;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 8; DNA, COMPLEMENTARY; DNA, NEOPLASM; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE DELETION; GENOTYPE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KERATINS; LIVER NEOPLASMS; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; MICROCIRCULATION; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 11144356989     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-003-0511-1     Document Type: Review

References (105)

1. Aruga A, Takasaki K, Hanyu F (1993) Establishment and characterization of liver metastatic model of human hepatoma in nude mice. Int Hepatol Commun 1:138-145
2. Bu W, Huang XW, Tang ZY (1997) The role of MMP-2 in the invasion and metastasis of hepatocellular carcinoma. Zhonghua Yixue Zazhi (Natl Med J China) 77:661-664 (Chin)
3. Bu W, Tang ZY, Sun FX, Ye SL, Liu KD, Xue Q, Chen J, Gao DM (1998) Effects of matrix metalloproteinase inhibitor BB-94 on liver cancer growth and metastasis in a patient-like orthotopic model LCI-D20. Hepato-Gastroenterol 45:1056-1061
4. Clark EA, Golub TR, Lander ES, et al (2000) Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406:532-535
5. Collonge-Rame MA, Bresson-Hadni S, Koch S, Carbillet JP, Blagosklonova O, Mantion G, Miguet JP, Heyd B, Bresson JL (2001) Pattern of chromosomal imbalances in non-B virus related hepatocellular carcinoma detected by comparative genomic hybridization. Cancer Genet Cytogenet 127:49-52
6. Eisenhauer EA (2003) From the molecule to the clinic- Inhibiting HER2 to treat breast cancer (editorial) N Engl J Med 344:841-842
7. He B, Tang ZY, Liu KD, Zhou G (1996) Analysis of the cellular origin of hepatocellular carcinoma by p53 genotype. J Cancer Res Clin Oncol 122:763-766
8. He B, Liu YK, Tang ZY, Xue Q (1997) Gene mutation and expression in metastatic model of human hepatocellular carcinoma in nude mice established by orthotopic implantation. Zhonghua Ganzangbing Zazhi (Chin J Hepatol) 5:245-245 (Chin)
9. Ijichi M, Takayama T, Matsumura M, Shiratori Y, Omata M, Makuuchi M (2002) alpha-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study. Hepatology 35:853-860
10. Ikeda K, Arase Y, Saitoh S, Kobayashi M, Suzuki Y, Suzuki F, Tsubota A, Chayama K, Murashima N, Kumada H (2000) Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor - a prospective randomized study of hepatitis C virus-related liver cancer. Hepatology 32:228-232
11. Jemal A, Thomas A, Murray T, Thum M (2002) Cancer statistics, 2002. CA Cancer J Clin 52:23-47
12. Ji XN, Ye SL, Li Y, Tian B, Chen J, Gao DM, Bao WH, Liu YK, Tang ZY (2003) Contribution of lung tissue extracts to invasion and migration of human hepatocellular carcinoma cells with various metastatic potentials. J Cancer Res Clin Oncol 129:556-564
13. Jiang XP, Liu KD, Zhou XD, Tang ZY, Zhang ZF, Zhang Y, Wu XF (1994) Identification of a new human nm23 gene, nm 23-H3b. Chin J Cancer Res 6:18-23
14. Jin F, Xiang YB, Gao YT (1998) Cancer survival in Shanghai, People's Republic of China. In: Sankaranaryanan R, Black RJ, Parkin DM (eds) Cancer survival in developing countries. IARC Scientific Publication No. 145. IARC, Lyon, pp. 37-50
15. Jinno K, Tanimizu M, Hyodo I, Nishikawa Y, Hosokawa Y, Doi T, Endo H, Yamashita T, Okada Y (1998a) Circulating vascular endothelial growth factor (VEGF) is a possible tumor marker for metastasis in human hepatocellular carcinoma. J Gastroenterol 33:376-382
16. Jinno K, Tanimizu M, Hyodo I, Nishikawa Y, Hosokawa Y, Endo H, Doi T, Mandai K, Ishitsuka H (1998b) Circulating platelet-derived endothelial cell growth factor increases in hepatocellular carcinoma patients. Cancer 82:1260-1267
17. Kim J, Kim SH, Lee SU, Ha GH, Kang DG, Ha NY, Ahn JS, Cho HY, Kang SJ, Lee YJ, Hong SC, Ha WS, Bae JM, Lee CW, Kim JW (2002) Proteome analysis of human liver tumor tissue by two-dimensional gel electrophoresis and matrixassisted laser desorption/ionization-mass spectrometry for identification of disease-related proteins. Electrophoresis 23:4142-4156
18. Kitay-Cohen Y, Amiel A, Ashur Y, Fejgin MD, Herishanu Y, Afanasyev F, Bomstein Y, Lishner M (2001) Analysis of chromosomal aberrations in large hepatocellular carcinomas by comparative genomic hybridization. Cancer Genet Cytogenet 131:60-64
19. Kobayashi T, Kubota K, Takayama T, Makuuchi M (2001) Telomerase activity as a predictive marker for recurrence of hepatocellular carcinoma after hepatectomy. Am J Surg 181:284-288
20. Kubo S, Nishiguchi S, Hirohashi K, Tanaka H, Shuto T, Kinoshita H (2002) Randomized clinical trial of long-term outcome after resection of hepatitis C virus-related hepatocellular carcinoma by postoperative interferon therapy. Br J Surg 89:418-422
21. Kusano N, Okita K, Shirahashi H, Harada T, Shiraishi K, Oga A, Kawauchi S, Furuya T, Sasaki K (2002) Chromosomal imbalances detected by comparative genomic hybridization are associated with outcome of patients with hepatocellular carcinoma. Cancer 94:746-751
22. Lau WY, Leung TW, Ho SK, Chan M, Machin D, Lau J, Chan AT, Yeo W, Mok TS, Yu SC, Leung NW, Johnson PJ (1999) Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial. Lancet 353:797-801
23. Li XM, Tang ZY, Zhou G, Liu YK, Ye SL (1998a) Significance of vascular endothelial growth factor mRNA expression in invasion and metastasis of hepatocellular carcinoma. J Exp Clin Cancer Res 17:13-17
24. Li XM, Tang ZY, Xue Q, Liu YK, Ye SL, Zhang XR, Zhao ZH (1998b) Suramin inhibits growth and metastasis of human hepatocellular cacinoma in nude mice. Zhonghua Shiyan Waike Zazhi (Chin J Exp Surg) 15:3-4 (Chin)
25. Li XM, Tang ZY, Chen FG (1998c) Gene transfer of dominant-negative flk-1 mutant inhibits angiogenesis, growth and metastases of human hepatocellular carcinoma in nude mice. Zhongguo Zhongliu Shengwu Zhiliao Zazhi (Chin J Cancer Biother) 5:160-162 (Chin)
26. Li XM, Sun HC, Tang ZY, Zhou J (1999a) Cytostatic calcium influx inhibitor carboxyamido- triazole inhibited angiogenesis induced by human hepatocellular carcinoma. Zhonghua Shiyan Waike Tazhi (Chin J Exp Surg) 16:489-490 (Chin)
27. Li XM, Tang ZY, Qin LX, Zhou J, Sun HC (1999b) Serum vascular endothelial growth factor is a predictor of invasion and metastasis in hepatocellula rcarcinoma. J Exp Clin Cancer Res 18:511-517
28. Li Y, Tang ZY, Ye SL, Liu YK, Chen J, Xue Q, Chen J, Gao DM, Bao WH (2001) Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. World J Gastroenterol 7:630-636
29. Li Y, Tang ZY, Ye SL, Liu BB, Liu YK, Chen J, Xue Q (2003) Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray. J Cancer Res Clin Oncol 129:43-51
30. Liang XH, Loncarevic IF, Tang ZY, Yu YQ, Zentgraf H, Schroder CH (1991) Resection of hepatocellular carcinoma: Oligocentric origin of recurrent and multinodular tumours. J Gastroenterol Hepatol 6:77-80
31. Liao Y, Tang ZY, Ye SL, Liu KD, Sun FX, Huang Z (2000) Modulation of apoptosis, tumorigenesity and metastatic potential with antisense H-ras oligodeoxynucleotides in a high metastatic tumor model of hepatoma: LCI-D20. Hepatogastroenterology 47:365-370
32. Liu H, Ye SL, Yang J, Tang ZY, Liu YK, Qin LX, Qiu SJ, Sun RX (2002) The microcell mediated transfer of human chromosome 8 into highly metastatic rat liver cancer cell line C5F. World J Gastroenterol 9:449-453
33. Liu H, Ye SL, Li WC, LiY, Liu YK, Qin LX, Qiu SJ, Sun RX, Chen J, Tang ZY (2003) Quantitative analysis of expression of TEY1 gene in liver cancer cells with different metastatic potential. Ai Zheng (Chin J Cancer) 22:561-565 (Chin)
34. Liu YK, Li Y, Ma XM, Chen J, Xue Q, Gao DM, Zhang Y, Ye SL, Tang ZY (2002) Regulation of liver cancer related gene and alpha fetal protein expression by cell differentiation agent II. Zhongguo Zhongliu 11:169-172 (Chin)
35. Mou DC, Cai SL, Peng JR, Wang Y, Chen HS, Pang XW, Leng XS, Chen WF (2002) Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells. Br J Cancer 86:110-116
36. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50-56
37. Muto Y, Moriwaki H, Ninomiya M, Adachi S, Saito A, Takasaki KT, Tanaka T, Tsurumi K, Okuno M, Tomita E, Nakamura T, Kojima T (1996) Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group. N Engl J Med 334:1561-1567
38. Muto Y, Moriwaki H, Saito A (1999) Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma. N Engl J Med 340:1046-1047
39. Niu Q, Tang ZY, Ma ZC, Qin LX, Zhang LH (2000a) Serum vascular endothelial growth factor is a potential biomarker of metastatic recurrence after curative resection of hepatocellular carcinoma. World J Gastroenterol 6:565-568
40. Niu Q, Tang ZY, Chen L, Ma ZC, Qin LX, Zhang LH (2000b) Basic fibroblast growth factor is a potential predictive marker of metastatic recurrence after resection of hepatocellular carcinoma. Zhonghua Waike Zazhi (Chin J Surg) 38:637-639 (Chin)
41. Niu Q, Tang ZY, Ma ZC, Qin LX, Bao WH, Zhang LH (2001) Relationship between serum matrix metalloproteinase-2 and metastasis and recurrence following radical hepatic resection in hepatocellular carcinoma. Zhonghua Ganzangbing Zazhi (Chin J Hepatol) 9:56-58 (Chin)
42. Okochi O, Hibi K, Uemura T, Inoue S, Takeda S, Kaneko T, Nakao A (2002) Detection of mitochondrial DNA alterations in the serum of hepatocellular carcinoma patients. Clin Cancer Res 8:2875-2878
43. Ono T, Yamanoi A, Nazmy El Assal O, Kohno H, Nagasue N (2001) Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: meta-analysis of three randomized controlled trials. Cancer 91:2378-2385
44. Pan H-W, Ou Y-H, Peng S-Y, Liu S-H, Lai P-L, Lee P-H, Sheu J-C, Chen C-L, Hsu H-C (2003) Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma. Cancer 98:119-127
45. Parasole R, Izzo F, Perrone F, Pignata S, Galati MG, Leonardi E, Castiglione F, Orlando R, Castello G, Esposito G, Gallo C, Daniele B (2001) Prognostic value of serum biological markers in patients with hepatocellular carcinoma. Clin Cancer Res 7:3504-3509
46. Parkin DM, Bray F, Ferlay J, Pisani P (2001) Estimsating the world cancer burden: globocan 2000. Int J Cancer 94:153-156
47. Poon RT, Ng IO, Lau C, Zhu LX, Yu WC, Lo CM, Fan ST, Wong J (2001a) Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study. Ann Surg 233:227-235
48. Poon RT, Ng IO, Lau C, Yu WC, Fan ST, Wong J (2001b) Correlation of serum basic fibroblast growth factor levels with clinicopathologic features and postoperative recurrence in hepatocellular carcinoma. Am J Surg 182:298-304
49. Qin LX, Tang ZY, Liu KD, Ye SL, Zhou G (1995) p53 mutations may be related to tumor invasiveness of human hepatocellular carcinoma in China. Oncol Rep 2:1175-1179
50. Qin LX, Tang ZY, Liu KD, Ye SL, He B, Zhang Y, Zhou G (1996) Alterations of CDKN2 (P16/MTS1) exon 2 in human hepatocellular carcinoma. Oncol Rep 3:405-408
51. Qin LX, Tang ZY, Sham JST, Ma ZC, Ye SL, Zhou XD, Wu ZQ, Trent JM, Guan XY (1999) The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma. Cancer Res 59:5662-5665
52. Qin LX, Tang ZY, Ye SL, Liu YK, Ma ZC, Zhou XD, Wu ZQ, Lin ZY, Sun FX, Tian J, Guan X-Y, Pack SD, Zhuang ZP (2001) Chromosome 8p deletion is associate with metastasis of human hepatocellular carcinoma when high and low metastatic models are compared. J Cancer Res Clin Oncol 127:482-488
53. Qin LX, Tang ZY, Ma ZC, Wu ZQ, Zhou XD, Ye QH, Yuan J, Huang LW, Jia HL, Sun HC, Wang L (2002a) P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection. World J Gastroenterol 8:459-463
54. Qin LX, Tang ZY (2002b) The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol 8:385-392
55. Qiu SJ, Ye SL, Wu ZQ, Tang ZY, Liu YK (1998) The expression of the mdm2 gene may be related to the aberration of the p53 gene in human hepatocellular carcinoma. J Cancer Res Clin Oncol 124:253-258
56. Saffroy R, Lelong JC, Azoulay D, Salvucci M, Reynes M, Bismuth H, Debuire B, Lemoine A (1999) Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma. Br J Cancer 79:604-610
57. Schwartz JD, Schwartz M, Mandeli J, Sung M (2002) Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials. Lancet Oncol 3:593-603
58. Seki S, Kitada T, Kawada N, Sakaguchi H, Kadoya H, Nakatani K, Satake K, Kuroki T (1999) Establishment and characteristics of human hepatocellular carcinoma cells with metastasis to lymph nodes. Hepatogastroenterology 46:2812-2817
59. Seow TK, Liang RC, Leow CK, Chung MC (2001) Hepatocellular carcinoma: from bedside to proteomics. Proteomics 1:1249-1263
60. Shao DM, Wang QH, Chen C, Shen ZH, Yao M, Zhou XD, Tang ZY, Gu JX (1999) N-Actylglucosaminyltransferase V activity in metastatic models of human hepatocellular carcinoma in nude mice. J Exp Clin Cancer Res 18:331-335
61. Steeg PS (2003) Angiogenesis inhibitors: motivator of metastasis? Nature Med 9:822-823
62. Sun FX, Tang ZY, Liu KD, Ye SL, Xue Q, Gao DM, Ma ZC (1996) Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues. Int J Cancer 66:239-243
63. Sun HC, Tang ZY, Zhou G, Li XM (1998) Kai-1 gene expression in hepatocellular carcinoma and its relationship with intrahepatic metastases. J Exp Clin Cancer Res 17:307-311
64. Sun HC, Li XM, Xue Q, Chen J, Gao DM, Tang ZY (1999a) Study of angiogenesis induced by metastatic and non-metastatic liver cancer by corneal micropocket model in nude mice. World J Gastroenterol 5:116-118
65. Sun HC, Zhang M, Tang ZY, Li XM, Wang L, Gao DM, Xue Q, Chen J (1999b) Inhibition of growth of LCI D20 hepatocellular carcinoma by Endostatin. Zhonghua Shiyan Waike Zazhi (Chin J Exp Surg) 116:491-492 (Chin)
66. Sun HC, Tang ZY, Li XM, Zhou YN, Sun BR, Ma ZC (1999c) Microvessel density of hepatocellular carcinoma: its relationship with prognosis. J Cancer Res Clin Oncol, 125:419-426
67. Sun HC, Tang ZY (2003) Preventive treatments for recurrence after curative resection of hepatocellular carcinoma - a literature review of randomized control trials. World J Gastroenterol 9:635-640
68. Sun JJ, Zhou XD, Liu YK, Tang ZY, Feng JX, Zhou G, Xue Q, Chen J (1999) Invasion and metastasis of liver cancer: expression of intercellular adhesion molecule 1. J Cancer Res Clin Oncol 125:28-34
69. Sun JJ, Zhou XD, Liu YK, Tang ZY, Sun RX, Zhao Y, Uemura T (2000) Inhibitory effects of syntheticβpeptide on invasion and metastasis of liver cancer. J Cancer Res Clin Oncol 126:595-600
70. Takayama T, Sekine T, Makuuchi M, Yamasaki S, Kosuge T, Yamamoto J, Shimada K, Sakamoto M, Hirohashi S, Ohashi Y, Kakizoe T (2000) Adoptive immunotherapy to lower post-surgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet 356:802-807
71. Tang ZY (1989) Small hepatocellular carcinoma. In: Tang ZY, Wu MC, Xia SS (eds) Primary liver cancer. Berlin, Springer, pp. 191-203
72. Tang ZY (2003) Thirty years' studies on surgery and related basic research of hepatocellular carcinoma. Ann Coll Surg HK 7:11-17
73. Tang ZY, Ma ZC (1989) Establishment of transplantable human hepatocellular carcinoma in nude mice and their use in studies of tumor markers and radioimmunodetection. In: Tang ZY Wu MC, Xia SS (eds) Primary liver cancer. Berlin, Springer, pp. 172-179
74. Tang ZY, Yu YQ, Zhou XD (1984) An important approach to prolonging survival further after radical resection of AFP positive hepatocellular carcinoma. J Exp Clin Cancer Res 3:359-366
75. Tang ZY, Qin LX, Wang XM, Zhou G, Liao Y, Weng Y, Jiang XP, Lin ZY, Liu KD, Ye SL (1998) Alterations of oncogenes, tumor suppressor genes and growth factors in hepatocellular carcinoma: with relation to tumor size and invasiveness. Chin Med J 111:313-318
76. Tang ZY, Zhou XD, Lin ZY, Yang BH, Ma ZC, Ye SL, Wu ZQ, Fan J, Liu YK, Liu KD, Qin LX, Tian J, Sun HC, He B, Xia JL, Qiu SJ, Zhou J (1999) Surgical treatment of hepatocellular carcinoma and related basic research with special reference to recurrence and metastasis. Chin Med J 112:887-891
77. Tian J, Tang ZY, Ye SL, Liu YK, Lin ZY, Chen J, Xue Q (1999) New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expression of the factors associated with metastasis. Br J Cancer 81:814-821
78. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AAM, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton M, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards AR (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999-2009
79. Wang G, Zhao Y, Liu X, Wang L, Wu C, Zhang W, Liu W, Zhang P, Cong W, Zhu Y, Zhang L, Chen S, Wan D, Zhao X, Huang W, Gu J (2001) Allelic loss and gain, but not genomic instability, as the major somatic mutation in primary hepatocellular carcinoma. Genes Chromosomes Cancer 31:221-227
80. Wang L, Tang ZY, Qin LX, Wu XF, Sun HC, Xue Q, Ye SL (2000a) High-dose and long-term therapy with interferon-alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential. Hepatology 32:43-48
81. Wang L, Tang ZY, Xue Q, Sun HC, Chen J, Zhang XR, Zhao ZH, Gao DM, Liu YK, Ye SL (2000b) Effect of interferon-α and all-trans retinoic acid on recurrence and metastasis of hepatocellular carcinoma. Zhonghua Shiyan Waike Zazhi (Chin J Exp Surg) 17:421-423 (Chin)
82. Wang XM, Tang ZY, Xue Q, Hong XY, Bao WH, Zou HQ (1995) Transforming growth factor α induces proliferation and expression of epidermal growth factor receptor in hepatocellular carcinoma cells. J Exp Clin Cancer Res 14:179-184
83. Witzigmann H, Geissler F, Benedix F, Thiery J, Uhlmann D, Tannapfel A, Wittekind C, Hauss J (2002) Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma. Surgery 131:34-43
84. Wong CM, Lee JM, Lau TC, Fan ST, Ng IO (2002) Clinico-pathological significance of loss of heterozygosity on chromosome 13q in hepatocellular carcinoma. Clin Cancer Res 8:2266-2272
85. Wong IH, Lau WY, Leung T, Yeo W, Johnson PJ (1999) Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis. Clin Cancer Res 5:4021-4027
86. Wu XF, Fan J, Lin ZY, Wu ZQ, Lu JZ, Zhou J, Tang ZY (2003) Quantitative analysis of AFP m RNA in portal, hepatic and peripheral venous blood of patients with HCC during liver surgery and its clinical significance. Zhonghua Gandan Waike Zazhi (Chin J Hepatobiliary Surg) 9:338-341 (Chin)
87. Xia JL, Yang BH, Tang ZY, Sun FX, Xue Q, Gao DM (1997) Inhibitory effect of the angiogenesis inhibitor TNP-470 on tumor growth and metastasis in nude mice bearing human hepatocellular carcinoma. J Cancer Res Clin Oncol 123:383-387
88. Xu XR, Huang J, Xu ZG, Qian BZ, Zhu ZD, Yan Q, Cai T, Zhang X, Xiao HS, Qu J, Liu F, Huang QH, Cheng ZH, Li NG, Du JJ, Hu W, Shen KT, Lu G, Fu G, Zhong M, Xu SH, Gu WY, Huang W, Zhao XT, Hu GX, Gu JR, Chen Z, Han ZG (2001) Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc Natl Acad Sci USA 98:15089-15094
89. Yang J, Qin LX, Ye SL, Liu YK, Li Y, Gao DM, Chen J, Tang ZY (2003) The abnormalities of chromosome 8 in two hepatocellular carcinoma cell lines with the same genetic background and different metastatic potential. J Cancer Res Clin Oncol 129:303-308
90. Yao M, Zhou XD, Zha XL, Shi DR, Fu J, He JY, Lu HF, Tang ZY (1997) Expression of the integrin α5 subunit and its mediated cell adhesion in hepatocellular carcinoma. J Cancer Res Clin Oncol 123:435-440
91. Yao M, Zhou DP, Jiang SM, Wang QH, Zhou XD, Tang ZY, Gu JX (1998a) Elevated activity of N-acetylglucosaminyltransferase V in human hepatocellular carcinoma. J Cancer Res Clin Oncol 124:27-30
92. Yao M, Zhou XD, Liu YK, Tang ZY (1998b) Expression of E-cadherin in hepatocellular carcinoma with high invasiveness. Zhonghua Xiaohua Zazhi (Chin J Digest) 18:31-33 (Chin)
93. Ye QH, Qin LX, Forgues M, He P, Kim JW, Peng AC, Simon R, Li Y, Robles AI, Chen YD, Ma ZC, Wu ZQ, Ye SL, Liu YK, Tang ZY, Wang XW (2003) Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nature Med 9:416-423
94. Ye YJ, Yu YQ, Tang ZY, Wan DF, Lu JZ, He LP (1998) Construction of nm23-Hl cDNA clone and the relationship between its mRNA expression and metastasis in hepatocellular carcinoma. Zhonghua Shiyan Waike Zazhi (Chin J Exp Surg) 15:17-18 (Chin)
95. Zhang LH, Qin LX, Ma ZC, Ye SL, Liu YK, Ye QH, Wu X, Huang W, Tang ZY (2003) Allelic imbalance regions on chromosomes 8p, 17p and 19p related to metastasis of hepatocellular carcinoma: comparison between matched primary and metastatic lesions in 22 patients by genomic microsatellite analysis. J Cancer Res Clin Oncol 129:279-286
96. Zhao X, Li J, He Y, Lan F, Fu L, Guo J, Zhao R, Ye Y, He M, Chong W, Chen J, Zhang L, Yang N, Xu B, Wu M, Wan D, Gu J (2001) A novel growth suppressor gene on chromosome 17p13.3 with a high frequency of mutation in human hepatocellular carcinoma. Cancer Res 61:7383-7387
97. Zhao X, He M, Wan D, Ye Y, He Y, Han L, Guo M, Huang Y, Qin W, Wang MW, Chong W, Chen J, Zhang L, Yang N, Xu B, Wu M, Zuo L, Gu J (2003) The minimum LOH region defined on chromosome 17p13.3 in human hepatocellular carcinoma with gene content analysis. Cancer Lett 190:221-232
98. Zheng Q, Tang ZY, Xue Q (1998a) Changes of PAI-1 and biological behaviour of human hepatocellular carcinoma in metastatic model of nude mice. Zhonghua Waike Zazhi (Chin J Surg) 36:687-689 (Chin)
99. Zheng Q, Tang ZY, Xue Q (1998b) Role of heparin on tumor growth and metastasis in model of human hepatocellular carcinoma in nude mice. Zhonghua Ganzangbing Tazhi (Chin J Hepatol) 6:151-152 (Chin)
100. Zheng Q, Tang ZY, Wu ZQ (1999) Changes of PAI-1 in plasma and tumor extract of patients with hepatocellular carcinoma. Zhonghua Xiaohua Zazhi (Chin J Digest) 19:16-18 (Chin)
101. Zheng Q, Tang ZY, Xue Q, Shi DR, Song HY, Tang HB (2000) Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor. J Cancer Res Clin Oncol 126:641-646
102. Zheng XY, Lin ZY, Tang ZY, Liu YK, Feng XL, Zhuang W (1998) The abundance of NM23-H1 mRNA is related with in situ microenvironment and intrahepatic metastasis in hepatocellular carcinoma. J Exp Clin Cancer Res 17:337-341
103. Zhou J, Tang ZY, Fan J, Wu ZQ, Li XM, Liu YK, Liu F, Sun HC, Ye SL (2000a) Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus. J Cancer Res Clin Oncol 126:57-61
104. Zhou J, Tang ZY, Fan J, Wu ZQ, Ji Y, Wang L, Bao WH, Qiu SJ (2000b) Study on inhibition of the growth and metastasis of LCID20 hepatocellular carcinoma by capecitabine. Zhonghua Shiyan Waike Zazhi (Chin J Exp Surg) 17:403-405 (Chin)
105. Zhou J, Tang ZY, Fan J, Wu ZQ, Ji Y, Ye SL (2001) The potential of plasma thrombomodulin as a biomarker of portal vein tumor thrombus in hepatocellular carcinoma. J Cancer Res Clin Oncol 127:559-564